Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 1893-1899

  Spanakis, N B ^c   Gorgoulis, V ^c   Mariatos, G ^c   Zacharatos, P ^c   Kotsinas, A ^c   Garinis, G ^c   Trigidou, R ^a   Karameris, A ^b   Tslmara Papastamatiou, H ^a   Kouloukousa, M ^c   Manolis, E N ^c   Kittas, C ^c  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

^c NONE

Author keywords

CDNK2; Chromosome locus 9p21 22; Lung cancer; MTS1 p16(INK4A); p16

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ARTICLE; CARCINOGENESIS; CELL CYCLE; CHROMOSOME 9P; CLINICAL FEATURE; CONTROLLED STUDY; GENE DELETION; GENE MAPPING; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; METHYLATION; MICROSATELLITE INSTABILITY; PATHOLOGY; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SMOKING HABIT; STAINING; TUMOR SUPPRESSOR GENE;

CARCINOMA, NON-SMALL-CELL LUNG; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 9; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P16; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MICROSATELLITE REPEATS; NEOPLASM PROTEINS; SEQUENCE DELETION;

EID: 0032791953     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Yoshitaka S, Kwun MF, Minna JD: Progress in understanding the molecular pathogenesis of human lung cancer. Bioch Biophys Acta 1378: F21-F59, 1998.
2. Harbour JW, Lai S-L, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 241: 353-357, 1988.
3. Takahashi T, Nau M, Chiba I, Birrer M, Rosenberg R, Vinocour M, Levitt M, Pass H, Gazdar A, Minna J: p53: a frequent target for genetic abnormalities in lung cancer. Science 246: 491-494, 1989.
4. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261, 1994.
5. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE, Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440, 1994.
6. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756, 1994.
7. Chin L, Pomerantz J, DePinho RA: The INK4a/ARF tumor suppressor some gene-two products-two pathways. TIBS 23: 291-296, 1998.
8. INK4B/MTS2- related cdk6 inhibitor, correlates with wildtype pRb function. Genes Dev 8: 2939-2952, 1994.
9. Hannon GJ, Beach D: p15INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371: 257-261, 1994.
10. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707, 1993.
11. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9: 3375-3378, 1994.
12. Okamoto A, Jiang W, Kim S-J, Spillare EA, Stoner GD, Weinstein IB, Harris CC: Overexpression of human cyclin D1 reduces the transforming growth factor β (TGF-β) type II receptor and growth inhibition by TGF-β1 in an immortalized human esophageal epithelial cell line. Proc Natl Acad Sci USA 91: 11576-11580, 1994.
13. Li Y, Nichols MA, Shay JW, Xiong Y: Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54: 6078-6082, 1994.
14. INK4 Science 267: 249-252, 1995.
15. INK4 in human cancer. Proc Natl Acad Sci USA 91: 11045-11049, 1994.
16. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PAT, Ally DS, Sheahan MD, Clark WHJr, Tucker MA, Dracopoli NC: Germline p16 mutations in familial melanoma. Nat Genet 8: 15-21, 1994.
17. Kamb A, Shattuck-Eidens D, Eeles R et al: Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 8: 22-26, 1994.
18. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8: 27-32, 1994.
19. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y: Frequent somatic mutation of the MTS1/CDK41 (multiple tumor suppressor/cyclin-.,dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54: 3396-3397, 1994.
20. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornour JM, Jones PA: Methylation of the 5 'CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55: 4531-4535, 1995.
21. Herman JG, Merlo A, Mao L, Lapidus RG, Issa J-PJ, Davidson NE, Sidransky D, Baylin SB: Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-4530, 1995.
22. Otterson GA, Khleif SN, Chen W, Coxon AB, Kaye FJ: CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5- aza 2′ deoxycytidine. Oncogene 11: 1211-1216, 1995.
23. Gazzeri S, Gouyer V, Vourtch C, Brambilla C, Brambilla E. Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene 16: 497-504, 1998.
24. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, Baylin SB, Herman JG: Proc Natl Acad Sci USA 95: 11891-11896, 1998.
25. World Health Organization. The World Health Organization histologic typing of lung tumours. Am J Clin Pathol 77: 123-136, 1982.
26. INK4A expression in resected non-small cell lung tumors. Cancer Res 56: 3415-3420, 1996.
27. Geradts J, Wilson PA: High frequency of aberrant p16INK4A expression in human breast cancer. Am J Pathol 149: 15-20, 1996.
28. Davis LG, Dibner MD, Battey JF: Basic methods in molecular biology. Amsterdam, Elsevier Sciense Publishing, 1989.
29. Fong KM, Zimmermann PV, Smith PJ: Microsatellite instability and other molecular abnormalities in non-small cell lung cancer. Cancer Res 55: 28-30, 1995.
30. Toft NJ, Arends MJ: DNA missmatch repair and colorectal cancer. J Pathol 185(2): 123-129, 1998.
31. Eshelman JR, Marcowitz SD: Microsatellite instability in inherited and sporadic neoplasms. Curr Opin Oncol 7: 83-89, 1995.